Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Antoinette Stroup

PATTERNS OF CARE/QUALITY OF CARE STUDY : DIAGNOSIS YEAR 2014

Multiple myeloma and immunoproliferative diseases Leukaemia Colorectum

David L Woodland

Immune Evolution in Cancer

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Brenda M Birmann

Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis

Multiple myeloma and immunoproliferative diseases

Ratneshwar Lal

Amyloid ion channels to design therapeutics for neurodegenerative diseases

Multiple myeloma and immunoproliferative diseases

Pathology

Robert Zygmunt Orlowski

Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Multiple myeloma and immunoproliferative diseases

Guido Franzoso

Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Trachea, bronchus and lung Stomach Prostate Pancreas Ovary Oesophagus Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system Bladder

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma Breast